Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Report this content

Biohit Oyj: Notice pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10

Biohit Oyj
STOCK EXCHANGE RELEASE
June 8, 2018 at 3.30 PM

Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Biohit Oyj has received an announcement from Biohit Healthcare (Hefei) Co., Ltd on June (city and country of residence: Hefei, Anhui, Peoples Republic of China) 8, 2018 in accordance with the Finnish Securities Market Act Chapter 9, Section 5.

According to the announcement, the total number of Biohit Oyj shares owned by Biohit Healthcare (Hefei) Co., Ltd has increased over thirty (30) per cent of the share capital of Biohit Oyj and total number of Biohit Oyj voting rights owned by Biohit Healthcare (Hefei) Co., Ltd has increased over twenty five (25) per cent of all voting rights on June 8, 2018.

Total positions of Biohit Healthcare (Hefei) Co., Ltd according to the notification:

 % of shares and voting rights

 
% of shares and voting rights through financial instruments

 
Total of both in %Total number of shares and voting rights of issuer
Resulting situation on the date on which the threshold was crossed or reached33.2 % of shares and
29.5 % of voting rights
  14,889,278 shares and
71,423,778 votes
Position of previous notification (if applicable)    

Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: shares and voting rights:

Class / type of shares
ISIN-code
Number of shares and voting rights % of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 ja 9:7)
A-shares850,000 5,7 % of shares and 23,8 % of votes 
B-shares4,095,415 27,5 % of shares and 5,7 % of votes 
SUBTOTAL A4,945,415 shares and
21,095,415 votes
33.2 % of shares and
29.5 % of votes

B: Financial instruments according to SMA 9:6a

Type of Financial instrument Expiration date Exercise / Conversion period Physical or cash settlement  Number of shares and voting rights% of shares and voting rights
      
      
      
 SUBTOTAL B  

Information on the party obliged to give notice of major shareholding:

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name% of shares and voting rights % of shares and voting rights through financial instruments Total of both
Liu Feng55.7143 % 55.7143 %

More information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi, www.biohit .fi

Biohit Oyj in brief

Biohit Oyj is a Finnish biotechnology company operating on a global scale. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit’s headquarters are located in Helsinki with subsidiaries in Italy and the UK.

Subscribe